Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Retinoid PUVA (RePUVA): systemic combination therapy in psoriasis].

C E Orfanos, H Pullmann, W Sterry

    Zeitschrift Fur Hautkrankheiten
    |July 15, 1978
    PubMed
    Summary

    RePUVA, a combination of retinoid and PUVA therapy, effectively treats psoriasis, even in patients resistant to standard PUVA. This approach reduces treatment duration and UVA exposure, minimizing potential long-term risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pioneers in Dermatology and Venereology: an interview with Prof. Constantin Orfanos.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    [Not Available].

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2016
    Same author

    From Hippocrates to modern medicine.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2007
    Same author

    Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings.

    Journal of cutaneous pathology·2007
    Same author

    HIV - associated and non - HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence.

    European journal of dermatology : EJD·2007
    Same author

    Antigen mimicry, epitope spreading and the pathogenesis of pemphigus.

    Tissue antigens·2006

    Area of Science:

    • Dermatology
    • Phototherapy
    • Pharmacology

    Context:

    • Psoriasis is a chronic inflammatory skin condition.
    • Standard PUVA (psoralen plus ultraviolet A) therapy is a common treatment.
    • Some patients exhibit resistance to conventional PUVA therapy.

    Purpose:

    • To evaluate the efficacy of RePUVA, a combined retinoid and PUVA treatment, for psoriasis.
    • To assess the optimal administration schedule for the retinoid component.
    • To compare RePUVA outcomes with standard PUVA treatment, particularly in PUVA-resistant cases.

    Summary:

    • RePUVA involves oral retinoid administration (50-75 mg daily) combined with systemic PUVA.
    • An overall response rate of 73% was observed, with 82.6% response in non-PUVA-resistant patients.
    • The most successful RePUVA schedule involved administering the retinoid before and concurrently with PUVA, requiring fewer sessions and lower UVA doses.

    Impact:

    • RePUVA demonstrates significant efficacy in treating psoriasis, including in patients resistant to standard PUVA.
    • This therapeutic approach may reduce treatment duration and total UVA dosage, thereby mitigating potential long-term side effects associated with PUVA.
    • Findings suggest RePUVA as a promising alternative or adjunct therapy for psoriasis management.

    Related Experiment Videos